文献速递复苏、休克与脓毒症儿科与产科急症重症综合管理与镇静镇痛

儿童脓毒性休克潜在表型的识别与转录组学评估

Identification and transcriptomic assessment of latent profile pediatric septic shock phenotypes.
PubMed 文献 · Crit Care · 2024-07-17
一句话结论在1071例需血管活性药支持的儿童脓毒性休克中,潜在剖面分析识别出两种表型,表型1占19.5%且复杂病程调整OR约4倍,并与固有免疫及内皮功能障碍相关。

该研究为前瞻性多中心儿童脓毒性休克观察性队列,纳入1071例第1天需血管活性药支持的患者,用临床、实验室和生物标志物数据做潜在剖面分析,并在内部验证集中训练支持向量机模型分配表型。识别出表型1(19.5%)和表型2(80.5%),表型1与复杂病程调整OR约4倍相关,以血管生成素-2/ Tie-2比值、血管生成素-2、可溶性血栓调节蛋白、IL-8、ICAM-1较高和Tie-2、血管生成素-1较低为特征。未发现表型与常见治疗及临床结局的显著交互作用;转录组分析显示表型1固有免疫反应基因过表达,主要由发育中的中性粒细胞驱动。新表型与反映宿主适应性反应的已有基因表达内型无统计学显著重叠,但整合亚分类方案显示不同内表型的生存概率存在差异。

要点

  • 在1071例第1天需血管活性药支持的儿童脓毒性休克中,潜在剖面分析识别出表型1(19.5%)和表型2(80.5%)。
  • 表型1与复杂病程调整OR约4倍相关(相对表型2),并以血管生成素-2/Tie-2比值、血管生成素-2、sTM、IL-8、ICAM-1较高和Tie-2、血管生成素-1较低为特征。
  • 未发现表型与常见治疗及临床结局之间存在显著交互作用。
  • 转录组分析显示表型1固有免疫反应基因过表达,主要由发育中的中性粒细胞驱动。
  • 新表型与已有基因表达内型无统计学显著重叠,但整合亚分类方案显示不同内表型的生存概率存在差异。

适用人群与场景

  • 前瞻性多中心儿童脓毒性休克观察性队列中第1天需血管活性药支持的患儿,共1071例。

研究设计与关键结果

  • 研究类型为前瞻性多中心儿童脓毒性休克观察性队列,纳入1071例第1天需血管活性药支持的患者,采用潜在剖面分析识别表型,并在内部验证集中训练支持向量机模型分配表型。
  • 识别出表型1(19.5%)和表型2(80.5%);表型1与复杂病程调整OR约4倍相关(相对表型2)。
  • 表型1特征为血管生成素-2/Tie-2比值、血管生成素-2、可溶性血栓调节蛋白(sTM)、白细胞介素8(IL-8)、细胞间黏附分子1(ICAM-1)浓度相对较高,Tie-2和血管生成素-1浓度相对较低(与表型2比较)。
  • 未发现表型与常见治疗及临床结局之间存在显著交互作用。
  • 转录组分析显示表型1固有免疫反应相关基因过表达,主要由发育中的中性粒细胞驱动。
  • 新表型与反映宿主适应性反应的已有基因表达内型之间无统计学显著重叠,但整合亚分类方案显示不同内表型的生存概率存在差异。

证据类型、等级与局限

  • 证据类型:前瞻性多中心观察性队列研究,采用潜在剖面分析和转录组分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,潜在剖面分析可重复识别具有高预后相关性的儿童脓毒性休克表型;待验证后,反映宿主反应不同方面的整合亚分类方案有望为危重患儿的靶向干预提供信息。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Sepsis poses a grave threat, especially among children, but treatments are limited owing to heterogeneity among patients. We sought to test the clinical and biological relevance of pediatric septic shock subclasses identified using reproducible approaches.

METHODS: We performed latent profile analyses using clinical, laboratory, and biomarker data from a prospective multi-center pediatric septic shock observational cohort to derive phenotypes and trained a support vector machine model to assign phenotypes in an internal validation set. We established the clinical relevance of phenotypes and tested for their interaction with common sepsis treatments on patient outcomes. We conducted transcriptomic analyses to delineate phenotype-specific biology and inferred underlying cell subpopulations. Finally, we compared whether latent profile phenotypes overlapped with established gene-expression endotypes and compared survival among patients based on an integrated subclassification scheme.

RESULTS: Among 1071 pediatric septic shock patients requiring vasoactive support on day 1 included, we identified two phenotypes which we designated as Phenotype 1 (19.5%) and Phenotype 2 (80.5%). Membership in Phenotype 1 was associated with ~ fourfold adjusted odds of complicated course relative to Phenotype 2. Patients belonging to Phenotype 1 were characterized by relatively higher Angiopoietin-2/Tie-2 ratio, Angiopoietin-2, soluble thrombomodulin (sTM), interleukin 8 (IL-8), and intercellular adhesion molecule 1 (ICAM-1) and lower Tie-2 and Angiopoietin-1 concentrations compared to Phenotype 2. We did not identify significant interactions between phenotypes, common treatments, and clinical outcomes. Transcriptomic analysis revealed overexpression of genes implicated in the innate immune response and driven primarily by developing neutrophils among patients designated as Phenotype 1. There was no statistically significant overlap between established gene-expression endotypes, reflective of the host adaptive response, and the newly derived phenotypes, reflective of the host innate response including microvascular endothelial dysfunction. However, an integrated subclassification scheme demonstrated varying survival probabilities when comparing patient endophenotypes.

CONCLUSIONS: Our research underscores the reproducibility of latent profile analyses to identify pediatric septic shock phenotypes with high prognostic relevance. Pending validation, an integrated subclassification scheme, reflective of the different facets of the host response, holds promise to inform targeted intervention among those critically ill.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Atreya MR, Huang M, Moore AR, et al. Identification and transcriptomic assessment of latent profile pediatric septic shock phenotypes. Crit Care. 2024. PMID: 39014377. doi:10.1186/s13054-024-05020-z

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。